Increase in Share Capital and Capital Surplus Through Conversion of Convertible Bonds
First written in FY2016-Q3. 18 of 19 entries say "Advanced", first in FY2017-Q3. Latest entry: FY2024-Q2.
11 other companies' latest entry also says "Advanced".
- FY2024-Q2AdvancedAnnual report
「The main factors were increases of ¥563 million each in share capital and capital surplus due to the exercise of stock acquisition rights, among other factors.」
The exercise of the 19th Series Stock Acquisition Rights, among other factors, increased share capital and capital surplus by ¥563 million each. - FY2024-Q1AdvancedAnnual report
「The stock acquisition rights issued by the Company on 6 March 2023 as the 19th Series Stock Acquisition Rights were exercised. As a result, share capital and capital surplus each increased by ¥501,766 thousand.」
The exercise of the 19th Series Stock Acquisition Rights increased share capital and capital surplus by ¥501,766 thousand each. - FY2023AdvancedAnnual report
「This was due to the exercise of the 19th Series Stock Acquisition Rights.」
The exercise of the 19th Series Stock Acquisition Rights resulted in the issuance of 20,325,000 shares and increased share capital and capital reserves by ¥573,858 thousand each. - FY2023-Q3AdvancedAnnual report
「Increase of ¥267 million each in share capital and capital surplus due to the exercise of stock acquisition rights, among other factors」
The exercise of the 19th Series Stock Acquisition Rights, among other factors, increased share capital and capital surplus by ¥267 million each. - FY2022-Q3AdvancedAnnual report
「The stock acquisition rights issued by the Company on 1 September 2021 as the 18th Series Stock Acquisition Rights were exercised, completing the exercise of all the rights. As a result, share capital and capital surplus each increased by ¥809,946 thousand.」
All of the 18th Series Stock Acquisition Rights were exercised, increasing share capital and capital surplus by ¥809,946 thousand each. - FY2022-Q2AdvancedAnnual report
「Total net assets increased by ¥744 million from the end of the previous fiscal year, as increases of ¥452 million in share capital, ¥452 million in capital surplus and ¥527 million in valuation difference on available-for-sale securities due to the exercise of stock acquisition rights, among other factors, outweighed decreases mainly due to the quarterly net loss of ¥678 million.」
The exercise of the 18th Series Stock Acquisition Rights increased share capital and capital surplus by ¥452 million each, and total net assets also increased by ¥744 million. - FY2022-Q1AdvancedAnnual report
「Total net assets increased by ¥48 million from the end of the previous fiscal year, as increases of ¥174 million in share capital, ¥174 million in capital surplus and ¥41 million in valuation difference on available-for-sale securities due to the exercise of stock acquisition rights, among other factors, outweighed decreases mainly due to the quarterly net loss of ¥342 million.」
The exercise of the 18th Series Stock Acquisition Rights, among other factors, increased share capital and capital surplus by ¥174 million each. - FY2021-Q3AdvancedAnnual report
「Number of the relevant convertible bond-type bonds with stock acquisition rights subject to exercise-price adjustment clauses exercised during the quarter (units) 31,950」
With respect to the 17th Series Stock Acquisition Rights, 31,950 units were exercised during the third quarter accounting period, resulting in the delivery of 3,195,000 shares and increasing share capital and capital reserves by ¥89.841 million each. - FY2021-Q2AdvancedAnnual report
「Number of the relevant convertible bond-type bonds with stock acquisition rights subject to exercise-price adjustment clauses exercised during the quarter (units) 44,500」
With respect to the 17th Series Stock Acquisition Rights, 44,500 units were exercised during the second quarter accounting period, resulting in the delivery of 4,450,000 shares and raising ¥256.064 million. Cumulatively, the figures were 158,050 units, 15,805,000 shares and ¥1,017.188 million, respectively. - FY2021-Q1AdvancedAnnual report
「As a result of increases of ¥294 million in share capital, ¥294 million in capital surplus and ¥329 million in the valuation difference on available-for-sale securities from the exercise of stock acquisition rights, total net assets increased by ¥573 million from the end of the previous fiscal year.」
The exercise of stock acquisition rights increased share capital and capital surplus by ¥294 million each, and total net assets also increased by ¥573 million. - FY2020-Q3AdvancedAnnual report
「Share capital of ¥572 million and capital surplus of ¥572 million from the exercise of stock acquisition rights」
The exercise of the 14th and 15th Series Stock Acquisition Rights increased share capital and capital surplus by ¥572 million each during the cumulative third quarter period. - FY2020-Q2AdvancedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
The exercise of the 14th Series Stock Acquisition Rights increased share capital and capital surplus by ¥229.696 million each. - FY2020-Q1AdvancedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
The exercise of the 14th Series Stock Acquisition Rights resulted in the issuance of 4,645,000 shares and increased share capital and capital reserves by ¥135.061 million each. - FY2019AdvancedAnnual report
「The main factors were an increase of ¥76 million in share capital and ¥76 million in capital surplus from the exercise of stock acquisition rights, offset by net loss for the period of ¥795 million, a ¥13 million decrease in stock acquisition rights and other factors.」
The exercise of stock acquisition rights increased share capital and capital surplus by ¥76 million each. - FY2019-Q3AdvancedAnnual report
「The details of the exercise of stock acquisition rights from 1 July 2019 to 6 August 2019 are as follows.」
Through the exercise of the 14th Series Stock Acquisition Rights, 365,000 shares were issued between 1 July and 6 August 2019 after the filing, and share capital and capital reserves increased by ¥10.870 million each. - FY2019-Q1AdvancedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
The exercise of the 13th Series Stock Acquisition Rights increased the number of issued shares by 100,000 and increased share capital and capital reserves by ¥4.838 million each. - FY2018-Q3AdvancedAnnual report
「Total net assets decreased by ¥1,730 million from the end of the previous consolidated fiscal year, despite increases of ¥576 million in share capital and ¥576 million in capital surplus from the conversion of convertible bond-type bonds with stock acquisition rights into shares and the exercise of stock acquisition rights, due to quarterly net loss attributable to owners of the parent of ¥2,611 million, a ¥296 million decrease in the valuation difference on available-for-sale securities and other factors.」
The exercise of stock acquisition rights in connection with the conversion of convertible bonds into shares increased share capital and capital surplus by ¥576 million each. - FY2017-Q3AdvancedAnnual report
「In addition, on 19 June 2017, the company issued new shares through a third-party allotment to Macquarie Bank Limited and シミックホールディングス株式会社 as the allottees. The 3rd Unsecured Convertible Bond-Type Bonds with Stock Acquisition Rights issued in June 2017 were partially converted into shares through the exercise of stock acquisition rights in June 2017.」
The company issued 1,372,400 shares through a third-party allotment and 876,915 shares through the exercise of the 3rd Unsecured Convertible Bond-Type Bonds with Stock Acquisition Rights. Share capital and capital reserves also increased. - FY2016-Q3First statedAnnual report
「Some of the Second Unsecured Convertible Bonds with Stock Acquisition Rights issued by the Company in October 2015 were converted into shares through the exercise of the stock acquisition rights in April and May 2016. As a result, during the nine-month period ended 30 June 2016, share capital and capital surplus each increased by ¥212,500 thousand.」
Part of the Second Unsecured Convertible Bonds with Stock Acquisition Rights was converted into shares, increasing share capital and capital surplus by ¥212,500 thousand each.